EUVIMEDEUVIMED entdecken
Crossref

Prognostic value of systemic immune-inflammation index in patients with non-valvular atrial fibrillation: SII score in patients using DOACs

Kahraman Cosansu, Sabiye Yilmaz, Cagin Mustafa Ureyen, Mustafa Gokhan Vural

Cardiovascular Journal of Africa · 2026

DOI: 10.5830/cvja-2025-107 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Journal of Africa, 2026. Verfasst von Kahraman Cosansu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Uskudar University Faculty of Medicine, Department of Cardiology. Email: Kahraman141@gmail.com. Hauptthemen laut MEDLINE: Atrial Fibrillation, Inflammation, Stroke, Neutrophils.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The systemic immune-inflammation index (SII) is a simple parameter that has been used to predict adverse outcomes in different clinical settings. The prognostic value of SII, an innovative biomarker of inflammation, in non-valvular atrial fibrillation (NVAF) patients has not been assessed. The aim of this study was to evaluate the prognostic value of SII in NVAF patients who were under direct oral anticoagulant (DOAC) medication. METHODS: A total of 467 patients with NVAF treated with DOACs from 2018 to 2021 were retrospectively enrolled in this cohort study. Demographics, medication, and outcome data were collected for each patient. SII was calculated from complete blood counts as the ratio of neutrophil-to-lymphocyte count multiplied by the platelet count. The primary outcome was major adverse events (MAEs), which include major bleeding, stroke, and death. RESULTS: Logistic regression analyses showed that the SII score was an important predictor of outcomes in NVAF patients. CONCLUSION: The SII may be a successful, non-invasive, and cost-effective parameter for predicting bleeding and stroke in patients with NVAF. It may be used as a useful risk stratification tool for these patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationInflammationStrokeNeutrophilsFactor Xa InhibitorsInflammation MediatorsLymphocytesHumansFemalePredictive Value of TestsMaleRisk FactorsRetrospective StudiesAgedRisk AssessmentTreatment OutcomeAdministration, OralAged, 80 and overHemorrhageMiddle AgedTime FactorsBiomarkersLymphocyte Count

Stichwörter der Autor:innen

atrial fibrillationdirect oral anticoagulantssystemic immune‐inflammation index

Substanzen

Factor Xa InhibitorsInflammation MediatorsBiomarkers

Autor:innen und Institutionen

  • Uskudar University Faculty of Medicine, Department of Cardiology. Email: Kahraman141@gmail.com.
  • Derince Education and Research Hospital, Department of Cardiology, University of Health Sciences.
  • Antalya Education and Research Hospital, Department of Cardiology, University of Health Sciences.
  • Ankara Education and Research Hospital, Department of Cardiology, University of Health Sciences.

Zitieren

APA

Cosansu, K., Yilmaz, S., Ureyen, C. M., & Vural, M. G. (2026). Prognostic value of systemic immune-inflammation index in patients with non-valvular atrial fibrillation: SII score in patients using DOACs. Cardiovascular Journal of Africa. https://doi.org/10.5830/cvja-2025-107

Vancouver

Cosansu K, Yilmaz S, Ureyen CM, Vural MG. Prognostic value of systemic immune-inflammation index in patients with non-valvular atrial fibrillation: SII score in patients using DOACs. Cardiovascular Journal of Africa. 2026. doi:10.5830/cvja-2025-107

BibTeX
@article{Cosansu2026,
  author = {Cosansu, Kahraman and Yilmaz, Sabiye and Ureyen, Cagin Mustafa and Vural, Mustafa Gokhan},
  title = {Prognostic value of systemic immune-inflammation index in patients with non-valvular atrial fibrillation: SII score in patients using DOACs},
  journal = {Cardiovascular Journal of Africa},
  year = {2026},
  doi = {10.5830/cvja-2025-107}
}
Kostenlos starten →